(Q38952185)

7 September 2017

title

A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis (English)

1 reference

7 September 2017

1 reference

Xiao Yang

1

1 reference

7 September 2017

Yidong Cheng

2

1 reference

7 September 2017

Pengchao Li

3

1 reference

7 September 2017

Jun Tao

4

1 reference

7 September 2017

Xiaheng Deng

5

1 reference

7 September 2017

Xiaolei Zhang

6

1 reference

7 September 2017

Min Gu

7

1 reference

7 September 2017

Qiang Lu

8

1 reference

7 September 2017

Changjun Yin

9

1 reference

7 September 2017

publication date

30 September 2014

1 reference

7 September 2017

1 reference

7 September 2017

volume

36

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

383-391

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-014-2617-2

7 September 2017

exact match

0 references

cites work

On the Origin of Cancer Cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Regulation of cancer cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Glycolysis inhibition for anticancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Many roads to maturity: microRNA biogenesis pathways and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

MicroRNA-21 is a novel promising target in cancer radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

HIF-1 mediates the Warburg effect in clear cell renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

mTOR links oncogenic signaling to tumor cell metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Glycolysis inhibition by 2-deoxy-D-glucose reverts the metastatic phenotype in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

A secreted PTEN phosphatase that enters cells to alter signaling and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Akt stimulates aerobic glycolysis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

TOR signaling in growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

21 January 2018

The two TORCs and Akt.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Upstream and downstream of mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

GLUT1 enhances mTOR activity independently of TSC2 and AMPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Activation of a metabolic gene regulatory network downstream of mTOR complex 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2617-2

Regulation of Aerobic Glycolysis by microRNAs in Cancer

21 January 2018

1 reference

12 December 2020

mTOR upregulation of glycolytic enzymes promotes tumor development

1 reference

12 December 2020

miR-181a mediates metabolic shift in colon cancer cells via the PTEN/AKT pathway

1 reference

12 December 2020

microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells

1 reference

12 December 2020

10.1007/S13277-014-2617-2

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1020655117

0 references

1 reference